The Efficacy and Safety of Careful Management of Self-Dose-Adjustment Intervention of Basal Insulin by the Nurse in Outpatients with T2DM

被引：0
|
作者：
Hu, Xiling
Yang, Xubin
Deng, Hongrong
Guo, Xiaodi
Yao, Bin
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-676-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
676-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The Efficacy of an Electronic System-Guided Follow-Up in Chinese T2DM Patients Initiating Basal Insulin Therapy
    Hu, Xiling
    Xie, Qingwei
    Zhang, Yao
    Guo, Xiaodi
    Liu, Shuhong
    Luo, Sihui
    Xu, Wen
    Yao, Bin
    Weng, Jianping
    DIABETES, 2017, 66 : A270 - A270
  • [32] Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed-Ratio Combination vs. Insulin Glargine in Japanese Patients with T2DM
    Kaneto, Hideaki
    Takami, Akane
    Spranger, Robert
    Amano, Atsushi
    Watanabe, Daisuke
    Niemoeller, Elisabeth
    DIABETES, 2019, 68
  • [33] HYPOGLYCEMIA RISK ASSOCIATED WITH BASAL INSULIN USE IN TYPE 2 DIABETES (T2DM): THE LIGHTNING STUDY
    Meneghini, L.
    Zhou, F. L.
    Bosnyak, Z.
    Berria, R.
    Jimenez, J.
    Bailey, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A45 - A46
  • [34] Indirect treatment comparison of efficacy and safety of insulin glargine 300 U/mL with once-daily-insulin premix in T2DM
    Ritzel, R.
    Ghosh, S.
    Emral, R.
    Malek, R.
    Malik, R.
    Zeng, L.
    Huang, Y.
    Mabunay, M. A.
    Landgraf, W.
    Guyot, P.
    Schenk, E.
    Pushkarna, D.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [35] Comparison of 3 Algorithms for Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus (T2DM)
    Dailey, George
    Aurand, Lisa
    Stewart, John
    Ameer, Barbara
    Zhou, Rong
    DIABETES, 2012, 61 : A263 - A263
  • [36] Persistence of the Use of Initially Prescribed Basal Insulin Therapies by People with Type 2 Diabetes (T2DM)
    Gordon, Jason P.
    Mcewan, Phil
    Home, Philip
    DIABETES, 2009, 58 : A148 - A149
  • [37] Early Insulin Initiation in T2DM Is Associated with Prevention of eGFR Decline and Lower Insulin Dose Requirements
    Kesavadev, Jothydev
    Warrier, Rohit
    Ramachandran, Lakshmy
    Shankar, Arun
    David, Ashwin
    Ajai, Neethu A.
    Sanal, Geethu
    Thampiraj, Kavitha
    Krishnan, Gopika
    Jothydev, Sunitha
    DIABETES, 2019, 68
  • [38] STRUCTURED GLUCOSE MONITORING AS PREDICTOR OF EFFECTIVENESS AND SAFETY OF INSULIN TREATMENT IN T2DM PATIENTS
    Strongin, L.
    Petrov, A.
    Suvorova, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A164 - A165
  • [39] Evaluation of the efficacy and safety of lixisenatide add-on treatment to basal insulin therapy among T2DM patients with different body mass indices from GetGoal trials
    Eto, Kazuhiro
    Naito, Yusuke
    Seino, Yutaka
    DIABETOLOGY & METABOLIC SYNDROME, 2015, 7
  • [40] Evaluation of the efficacy and safety of lixisenatide add-on treatment to basal insulin therapy among T2DM patients with different body mass indices from GetGoal trials
    Kazuhiro Eto
    Yusuke Naito
    Yutaka Seino
    Diabetology & Metabolic Syndrome, 7
12345